Seattle, WA – October 24, 2025 – Seattle Clinical Research Center (SCRC) is proud to recognize the recent FDA approval of elinzanetant (brand name Lynkuet), developed by Bayer, for the treatment of moderate to severe vasomotor symptoms (hot flashes) associated with menopause. SCRC participated in multiple clinical trials evaluating elinzanetant, contributing to the pivotal data that helped support its approval. As a … Read more